), 85 million people are obese, and 15 million people are morbidly obese. 5 In this article, we describe the tools that have been used historically to diagnose obesity and outline new efforts to redefine important early markers for obesity and obesityrelated health risks in patients.
Waist circumference is also a method often used to diagnose metabolic syndrome in overweight and obese patients. When a large WC is factored into BMI-associated disease risk, there is an increased disease risk in the overweight and class I obesity groups ( Table 2 ).
The additional risk brought on by a large WC remains unchanged in obesity classes higher than class II because WC has little added predictive power of disease risk beyond that of BMI. The WC, therefore, is less useful as an independent marker of medical risk when the BMI is greater than 39. Overall risk is independently associated with excess abdominal fat (WC >40 inches intra-abdominal fat that is greater than subcutaneous or total body fat and a relative decrease in peripheral fat that is greater than central fat-free mass resulting from the loss of skeletal muscle. 6 
Ethnic Differences in Measuring Obesity
A 2006 study 7 suggested that current overweight, obesity, and central adiposity guidelines based on white populations are not appropriate for other ethnic populations, such as Asians, Hispanics, and blacks. The
Nurses' Health Study highlighted the ethnic differences in BMI. 7 In the study, 78,000 US women without type 2 diabetes mellitus (T2DM) had their weight tracked for 20 years to determine whether any ethnic differences in the development of T2DM existed. It was observed that Asians had more than double the Risk is accelerated by the coexistence of other factors, such as those listed above. In the Framingham Heart Study, obesity was observed to be an independent risk factor for all-cause mortality in a 30-year in men and >35 inches in women). 11 The visceral deposition of adipose tissue is easily ascertained by measuring WC or the waist-to-hip ratio.
REVIEW
Waist circumference was shown to be a surrogate marker for intra-abdominal adiposity in a study of 81 men and 70 women. 13 In this study, WC strongly correlated with intra-abdominal adiposity as measured using computed tomography or magnetic resonance imaging, which are considered the criterion standards for imaging adipose tissue. 13 In 1998, an expert panel organized by the National Heart, Lung, and Blood Institute recommended that WC be measured as part of the initial assessment of overweight and obese patients (BMI <35) and be used to monitor the efficacy of weight loss therapy.
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Metabolic Syndrome
The increased disease risk in the overweight and class I obesity groups can be explained by metabolic syndrome, also known as insulin-resistant syndrome. follow-up of male participants. 17 Multivariate analyses revealed a strong positive association between baseline weight and death rate for nonsmoking men who were overweight (3.9 times higher than that of men of normal weight). 17 Another prospective study that followed more than 1 million adults for 14 years noted a strong relationship between BMI and increased risk for all-cause mortality and death due to cardiovascular disease in nonsmokers and in men and women with no history of coronary heart disease. 
Primary, Secondary, and Tertiary Prevention and Treatment
The AACE/ACE's algorithmic approach to the diagnosis, evaluation, and care of obese patients takes into account BMI and the extent to which being overweight or obese has affected patients' health or the severity of a specific health condition.
For patients whose weight is normal, the treat- A 5% to 10% weight loss through diet and increased physical activity has been shown to induce a 30% or more loss of visceral adipose fat. 24 Mobilization of atherogenic visceral fat substantially reduces the risks of adverse consequences of metabolic syndrome. 13 Preferential mobilization of visceral fat explains the improvements in atherogenic dyslipidemia, insulin sensitivity, and hypertension. 25 Studies are in progress to assess the cardiometabolic risk profile after weight loss and mobilization of visceral fat. , and hyperlipidemia, which can be achieved
